← Browse by Condition
Medical Condition

systemic lupus erythematosus acute

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06428188 Phase 1, Phase 2
Recruiting

Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases

Enrollment
60 pts
Location
China
Sponsor
Essen Biotech
View Trial →